Analyst Price Targets — DNA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 25, 2025 11:43 am | — | BTIG | $9.00 | $12.05 | TheFly | Ginkgo Bioworks price target raised to $9 from $6 at BTIG |
| August 23, 2024 7:02 am | Mark Massaro | BTIG | $7.00 | $8.30 | TheFly | Ginkgo Bioworks price target lowered to $7 from $8 at BTIG |
| November 29, 2022 4:38 am | — | Berenberg Bank | $6.00 | $1.84 | Benzinga | Berenberg Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $6 |
| August 16, 2022 9:33 am | — | BTIG | $6.00 | $3.74 | Benzinga | BTIG Maintains Buy on Ginkgo Bioworks Holdings, Raises Price Target to $6 |
| June 16, 2022 9:07 am | — | Jefferies | $4.35 | $2.59 | Benzinga | Jefferies Maintains Buy on Ginkgo Bioworks Holdings, Lowers Price Target to $4.35 |
| March 3, 2022 12:00 am | Steven Mah | Cowen & Co. | $12.00 | $3.86 | Pulse 2.0 | Ginkgo Bioworks, Inc. (DNA) Stock: $12 Price Target And Outperform Rating |
Latest News for DNA
Completed acquisition of the DNA X cryptocurrency trading platform Closed sale of the Company's mobile device assets to NEXA in January 2026 Focused on enhancing the DNA X trading platform to prepare the platform for its initial growth phase San Diego, California--(Newsfile Corp. - April 14, 2026) - DNA X, Inc. (NASDAQ: SONM), a provider of cryptocurrency trading services, today announced its financial results for…
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) insider Reshma Shetty sold 124,727 shares of the company's stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $6.43, for a total value of $801,994.61. Following the completion of the transaction, the insider directly owned 436,422
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) major shareholder Barry Canton sold 13,155 shares of Ginkgo Bioworks stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $6.93, for a total value of $91,164.15. Following the sale, the insider directly owned 351,684 shares in
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) insider Reshma Shetty sold 13,155 shares of the stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $6.93, for a total value of $91,164.15. Following the completion of the sale, the insider owned 351,684 shares of the company's
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA - Get Free Report) major shareholder Barry Canton sold 13,116 shares of the firm's stock in a transaction that occurred on Thursday, April 9th. The shares were sold at an average price of $6.40, for a total transaction of $83,942.40. Following the completion of the sale, the insider owned 338,568
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DNA.
U.S. House Trading
No House trades found for DNA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.